|
|
|
|
|
||||||||||||||||
| Chapter 5 – Therapeutic Options for Targeting the Immune System, Part I: Corticosteroids and Small Molecule Immunosuppressive Drugs | ||||||||||||||||
|
||||||||||||||||
|
Activity Goal The goal of this CME/CE program is to address the clinicians' needs in assessing the role of the immune system in the underlying pathophysiology of common dermatologic conditions, current strategies for immunomodulation, and novel therapeutic strategies in the management of dermatologic conditions. |
||||||||||||||||
|
Target Audience This CME/CE program is intended for dermatologists, general/internal medicine providers, nurse practitioners, nurses, physician assistants, and pharmacists who care for patients with dermatologic conditions. |
||||||||||||||||
Learning Objective
|
||||||||||||||||
| top |
||||||||||||||||
|
CME Information: Physicians
Statement of Accreditation Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Credit Designation Projects In Knowledge® designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CE Information: Nurses Dermatology Nurses' Association (DNA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA. Provider approved by the California Board of Registered Nursing, Provider Number CEP5708. CE Information: Pharmacists  Projects In Knowledge® is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been planned and implemented in accordance with the ACPE Criteria for Quality and Interpretive Guidelines. This chapter is worth up to 2.00 contact hours (0.2 CEUs). The ACPE Universal Activity Number assigned to this Application-type activity is 0052-0000-11-2279-H01-P. Pharmacists should only claim credit commensurate with the extent of their participation in the activity. top |
||||||||||||||||
|
Disclosure Information The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR). Cathleen K. Case, MS, ANP-BC, DCNP, has disclosed no significant relationships. Nikki A. Levin, MD, PhD, has received contracted research from Amgen, Inc. Nancy J. Nordenson, MT (ASCP), MFA (medical writer), has disclosed no significant relationships. Off-label drug statement This activity will include off-label discussion of dermatologic and immunologic therapies. Peer Reviewer has disclosed no significant relationships. Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no significant relationships to disclose. Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no significant relationships to disclose. Projects In Knowledge’s staff members have no significant relationships to disclose. top |
||||||||||||||||
Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process. The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge. This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
|
||||||||||||||||
|
|
||||||||||||||||
|
|
|
|
|
These independent CME/CE activities are supported by an educational grant from Abbott.
|
|
|
Release Date: November 28, 2011. Termination Date: March 31, 2014. |
|
Estimated time for completion of this activity: CME: 2.00 hours CNE: 37.20 minutes CPE: 2.00 hours |
|
CME/CE Instructions To obtain CME/CE credit for this activity:
There is no fee for this activity. |
|
| For questions about content or obtaining CME credit, please contact us. | |
